IP Verse

Combination Of A Pd-1 Antagonist And A Vegfr Inhibitor For Treating Cancer

Patent No. EP3498734 (titled "Combination Of A Pd-1 Antagonist And A Vegfr Inhibitor For Treating Cancer") was filed by Merck Sharp & Dohme on Feb 3, 2015. The application was issued on Sep 1, 2021.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (9)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
KONIG SZYNKA TILMANN VON RENESSEJun 1, 2022KONIG SZYNKA TILMANN VON RENESSE DUSSELDORF
KONIG SZYNKA TILMANN VON RENESSEJun 1, 2022KONIG SZYNKA TILMANN VON RENESSE PATENTANWALTE PARTNERSCHAFT MBB DUSSELDORF
PAJAROMay 31, 2022ALT
PAJAROMay 31, 2022BIRD & BIRD
POHLMANMay 31, 2022POHLMAN
BOULT WADE TENNANTMay 27, 2022-
SYMBIOSISMay 26, 2022SYMBIOSIS
HOFFMANN EITLEMay 20, 2022-
WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBBMay 13, 2022WICHMANN

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3498734

MERCK SHARP & DOHME
Application Number
EP18205542A
Filing Date
Feb 3, 2015
Status
Revoked
Jul 18, 2025
Publication Date
Sep 1, 2021
External Links
Slate, Register , Google Patents